而且,如何识别有复发风险FSGS和复发性FSGS(rFSGS)的管理尚无共识或临床指南,因此既往而言,许多肾内科医生不推荐FSGS患者接受肾移植治疗。 2023年12月21日,FSGS患者肾移植专家共识在kidney international杂志上发布,该共识涉及了rFSGS的定义、流行病学、...
1.Shoji J, Goggins WC, Wellen JR, et al. Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study. Tr...
1. Kremers WK, Denic A, Lieske JC, et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 2015; 30:2034. 2. De Vriese AS, Sethi S, Nath KA, et al. Differentiating Primary, Genetic, and Secondary ...
Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation.BMC Nephrology, 2023. Available at: BMC Nephrology Management of recurrent focal segmental glomerulosclerosis (FSGS) post kidney transplant.Nephrology Dialysis Transplantation, 2023. Av...
11、 steroids,Braun N,Cochrane Database Syst Rev 2008 Ponticelli C,Kidney Int 1993 Meyrier A, Kidney Int 1994 Cattran DC,Kidney Int 2007,FK-506,Segarra A, Nephrol Dial Transplant 2002 Loeffler K, Pediatr Nephrol 2004,Tacrolimus Therapy in Adults With Steroid- andCyclophosphamide-Resistant Nephr...
[1]Abbott KC, Sawyers ES, Oliver JD 3rd, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37:366. [2]Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glo...
关键词 利妥昔单抗 局灶节段性肾小球硬化 B 细胞 足细胞 酸性鞘磷脂酶样磷酸二酯酶 3b Mechanism and efficacy of rituximab in idiopathic focal segmental glomerulosclerosis MIN Min,ZHANG Jiong,WANG Jinquan National Clinical Research Center of Kidney Disease,Jinling Hospital,Nanjing Medical University, ...
参考文献 [1] Bayrakci US,Baskin E,Sakalli H,et al.Rituximab for post- transplant recurrences of FSGS[J]. Pediatr Transplant,2009, 13(2):240-243. [2] Munoz AS, Rioveros AA, Cabanayan-Casasola CB,et al. Rituximab in highly sensitized kidney transplant recipients[J]. Transplant Proc,...
1. Kremers WK, Denic A, Lieske JC, et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study. Nephrol Dial Transplant 2015; 30:2034. 2. De Vriese AS, Sethi S, Nath KA, et al. Differentiating Primary, Genetic, and Secondary ...
transplant outcomesrecurrencerenal transplantationrisk factorshumansadultkidney transplantationgraft survivalrituximabBACKGROUND AND OBJECTIVES :FSGS recurrence after kidney transplantation is a major risk factor for graft loss. However, the natural history, clinical predictors, and response to treatment remain ...